001452014 000__ 06155cam\a2200577\a\4500
001452014 001__ 1452014
001452014 003__ OCoLC
001452014 005__ 20230310003336.0
001452014 006__ m\\\\\o\\d\\\\\\\\
001452014 007__ cr\un\nnnunnun
001452014 008__ 221231s2022\\\\sz\\\\\\o\\\\\001\0\eng\d
001452014 019__ $$a1356437167$$a1363109894
001452014 020__ $$a9783031154782$$q(electronic bk.)
001452014 020__ $$a3031154789$$q(electronic bk.)
001452014 020__ $$z3031154770
001452014 020__ $$z9783031154775
001452014 0247_ $$a10.1007/978-3-031-15478-2$$2doi
001452014 035__ $$aSP(OCoLC)1356574611
001452014 040__ $$aEBLCP$$beng$$cEBLCP$$dGW5XE$$dSFB$$dYDX$$dUKAHL
001452014 049__ $$aISEA
001452014 050_4 $$aRA644.C67
001452014 08204 $$a614.592414$$223/eng/20230123
001452014 24500 $$aCardiovascular complications of COVID-19 :$$bacute and long-term impacts /$$cMaciej Banach, editor.
001452014 260__ $$aCham :$$bSpringer,$$c2022.
001452014 300__ $$a1 online resource (434 p.).
001452014 336__ $$atext$$btxt$$2rdacontent
001452014 337__ $$acomputer$$bc$$2rdamedia
001452014 338__ $$aonline resource$$bcr$$2rdacarrier
001452014 4901_ $$aContemporary Cardiology
001452014 500__ $$aChapter 6: Myocardial Injury in COVID-19 (Epidemiology, Influence on Prognosis, Pathogenesis, Treatment)
001452014 500__ $$aIncludes index.
001452014 5050_ $$aIntro -- Foreword -- Preface -- Acknowledgments -- Contents -- Part I: General Part -- Chapter 1: Biology of SARS-CoV-2 Coronavirus -- Origin, Structure, and Variants -- Introduction -- Method of Search -- The SARS-CoV-2 Biology -- The SARS-CoV-2 Origins -- HCoV-229E -- HCoV-OC43 -- SARS-CoV -- HCoV-NL63 -- HCoV-HKU1 -- MERS-CoV -- SARS-CoV-2 -- The SARS-CoV-2 Structure -- SARS-CoV-2 Variants -- Conclusion -- References -- Chapter 2: COVID-19 Epidemiology and Differences in Incidence and Mortality Between Countries -- Origins -- Asian Countries -- COVID-19 in the United States of America
001452014 5058_ $$aCanada -- Mexico -- Peru -- Brazil -- Colombia -- Europe -- Russia -- Ukraine -- Italy -- Poland -- South Africa -- Antarctica -- References -- Chapter 3: Clinical Symptoms and Course of COVID-19 -- SARS-CoV-2 Transmission -- Virus Replication -- Immunological Responses and Cytokine Storm (CS) -- Virus Variants and Associated Evolution in the Clinical Course -- Clinical Stages of COVID-19 [21] -- Mild and Asymptomatic Stage -- Symptomatic Stage -- Severe Disease -- Acute Respiratory Distress Syndrome/Critical Stage -- Clinical Symptoms of COVID-19
001452014 5058_ $$aGeneral Symptoms in the Early, Asymptomatic and Mild Infection -- Respiratory Manifestations -- Extra-Respiratory Manifestations -- Hematologic Abnormalities -- Prothrombotic Events -- Cardiovascular Involvement -- Neurological and Neuropsychiatric Manifestations -- Kidney Involvement -- Gastrointestinal and Hepatic Involvement -- Skin Associated COVID-19 Symptoms -- COVID-19 in Children -- Long COVID-19 -- Conclusions -- References -- Chapter 4: Risk Factors of Developing COVID-19 and its Severe Course -- COVID-19 and Related Cardiovascular Risk Factors -- Age -- Sex -- Smoking -- Diabetes
001452014 5058_ $$aObesity -- Hypertension -- Dyslipidemia -- Chronic Kidney Disease -- Additional Markers of Increased CV Disease Risk in COVID-19 -- References -- Chapter 5: Prognosis in COVID-19 Patients: Statistics, Risk Factors -- Introduction -- Demographic Features -- Age and Sex -- Ethnicity -- Clinical Symptoms -- Comorbidities and the Course of COVID-19 -- Hypertension -- Diabetes Mellitus -- Obesity -- Chronic Obstructive Pulmonary Disease (COPD) -- Chronic Kidney Disease -- Cancer -- Special Conditions and Populations of Patients and the COVID-19 Course -- Smoking -- Pregnancy -- Children
001452014 5058_ $$aSelected Laboratory Parameters Values and the COVID-19 Course -- Leukocyte Counts -- Lymphocyte Counts -- Neutrophil Counts -- Platelet Counts -- C-Reactive Protein (CRP) -- Procalcitonin (PCT) -- Lactate Dehydrogenase (LDH) -- Interleukin 6 (IL-6) -- D-Dimer -- Ferritin -- Albumin -- Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) -- Cardiac Troponin -- Complications -- Reinfection -- Conclusions and Take-Home Message -- References -- Part II: Cardiovascular Complications of the Acute Phase of COVID-19
001452014 506__ $$aAccess limited to authorized users.
001452014 520__ $$aThis book is the first comprehensive approach on COVID-19 cardiac complications, both during the acute phase as well as in the long-COVID period. It provides an up-to-date and highly illustrated summary of the biology of SARS-CoV-2, the course of COVID-19, risk factors that worsen the disease in COVID-19 patients, clinical features of COVID-19 patients, COVID-19 cardiological complications, treatment, and prevention methods, and long-term cardiological aspects of COVID-19. Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors. Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs.
001452014 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 23, 2023).
001452014 650_0 $$aCOVID-19 (Disease)$$xComplications.
001452014 650_0 $$aCardiovascular system$$xDiseases.
001452014 655_0 $$aElectronic books.
001452014 7001_ $$aBanach, Maciej,$$eeditor.
001452014 77608 $$iPrint version:$$aBanach, Maciej$$tCardiovascular Complications of COVID-19$$dCham : Springer International Publishing AG,c2023$$z9783031154775
001452014 830_0 $$aContemporary cardiology (Totowa, N.J.)
001452014 852__ $$bebk
001452014 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-15478-2$$zOnline Access$$91397441.1
001452014 909CO $$ooai:library.usi.edu:1452014$$pGLOBAL_SET
001452014 980__ $$aBIB
001452014 980__ $$aEBOOK
001452014 982__ $$aEbook
001452014 983__ $$aOnline
001452014 994__ $$a92$$bISE